TTM Capital was rated as one of the TOP 50 Early-Stage Venture Capital Institutions in China Dec.08.2023
TTM Capital was awarded two honors by China Bridge: China's Best Return Venture Capital Institution Jan.18.2024
Synthesize Momentum, Forge Innovation | 2026 TTM Capital Investment Summit Successfully Held Mar.23.2026
TTM Family | Tosun Pharmaceutical Completes US$40 Million Angel Round to Accelerate Pipeline Development and Support Its Growth as a Leader in Innovative Oncology Therapies Feb.03.2026
